{"SPADE_N_15708": {"Sequence Information": {"Peptide Name": "Lycosin-I", "Sequence": "RKGWFKAMKSIAKFIAKEKLKEHL", "Sequence Length": 24, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Lycosa singorensis", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis.", "Pubmed ID": "23638903", "Reference": "Curr Mol Med. 2013;13:900-910", "Author": "Tan H, Ding X, Meng S, Liu C, Wang H, Xia L, Liu Z, Liang S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23638903"}, {"Title": "A novel spider peptide toxin suppresses tumor growth through dual signaling pathways.", "Pubmed ID": "22882120", "Reference": "Curr Mol Med. 2012;12:1350-1360", "Author": "Liu Z, Deng M, Xiang J, Ma H, Hu W, Zhao Y, Li DW, Liang S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22882120"}], "Mass": 2888.52, "PI": 10.39, "Net Charge": 7, "Hydrophobicity": -0.61, "Frequent Amino Acids": "KAE", "Absent Amino Acids": "CDNOPQTUVY", "Basic Residues": 9, "Acidic Residues": 2, "Hydrophobic Residues": 10, "Polar Residues": 14, "Positive Residues": 9, "Negative Residues": 2, "SPADE ID": "SPADE_N_15708", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15768", "Similarity": 1.0, "Sequence": "RKGWFKAMKSIAKFIAKEKLKEHL"}, {"SPADE_ID": "SPADE_UN_15766", "Similarity": 1.0, "Sequence": "KGWFKAMKSIAKFIAKEKLKEHL"}, {"SPADE_ID": "SPADE_UN_15769", "Similarity": 1.0, "Sequence": "WFKAMKSIAKFIAKEKLK"}], "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=40 µM,Human erythrocytes:37% Hemolysis=200 µM,Human hepatocyte cells HL-7702 (L02):25% Killing=40 µM,Mouse skin epidermal cells JB6:20% Killing=40 µM", "Target Organism": "Escherichia coli CGMCC 1.1369(MIC=25µM),Shigella dysenteriae CPCC 160015(MIC=3.1µM),Shigella dysenteriae CPCC 160015(MIC=50µM),Proteus vulgaris CGMCC 1.1651(MIC=6.2µM),Pseudomonas aeruginosa CMCC 10104(MIC=6.2µM),Salmonella typhimurium CGMCC 1.1174(MIC=12.5µM),Klebsiella aerogenes CGMCC 1.2021(MIC=12.5µM),Acetobacterium wieringae CGMCC 1.2033(MIC=3.1µM),Alcaligenes faecalis CGMCC 1.924(MIC=3.1µM),Klebsiella pneumoniae CPCC 160022(MIC=3.1µM),Klebsiella pneumoniae CPCC 160022(MIC=50µM),Enterobacter cloacae CGMCC 1.58(MIC=50µM),Providencia rettgeri CMCC 49256(MIC=6.2µM),Bacillus subtilis CGMCC 1.88(MIC=12.5µM),Staphylococcus aureus AB94004(MIC=3.1µM),Staphylococcus aureus AB94004(MIC=12.5µM),Corynebacterium glutamicum CGMCC 1.818(MIC=3.1µM),Staphylococcus epidermidis ACCC02744(MIC=3.1µM),Staphylococcus epidermidis ACCC02744(MIC=12.5µM),Bacillus thuringiensis 4.0718(no activity data),Bacillus thuringiensis serovar kurstaki HD1(no activity data),Bacillus thuringiensis serovar israelensis H14(MIC=12.5µM),Micrococcus luteus AB206228(MIC=3.1µM),Bacillus cereus CMCC 1.126(MIC=6.2µM),Enterococcus faecalis CGMCC 1.100(MIC=25µM),Tetragenococcus halophilus CGMCC 1.2492(MIC=3.1µM),Saccharomyces cerevisiae CGMCC 2.1619(MIC=50µM),Candida albicans CMCC 98001(MIC=50µM),Beauveria bassiana CGMCC 3.3576(MIC=6.2µM),Penicillium sp. ATCC 30106(MIC=3.1µM),Aspergillus flavus CGMCC 3.6433(MIC=3.1µM),Human cervical carcinoma HeLa(LC90=40µM),Human hepatocellular carcinoma HepG2(LC90=40µM),Human lung carcinoma A549(LC90=40µM),Human lung carcinoma H1299(LC90=40µM),Human fibrosarcoma HT1080(LC90=40µM),Human prostate cancer DU145(LC90=40µM),Human colon adenocarcinoma HCT 116(LC90=40µM)"}}}